NYSE:IBM

IBM Common Stock (IBM)

306.13
+6.61 (2.21%)
as of Jul 7, 2026, 8:00:00 pm Market Open.
276 watching
0
Investor Insights
star iconJul 7, 2026, 12:00 am

This summary was created by AI, based on 25 opinions in the last 12 months.

IBM Common Stock has received mixed reviews from various experts, showcasing a blend of confidence and caution regarding its future. The stock has experienced a significant drop, down 17% this year, yet many analysts see potential growth driven by key sectors like AI and quantum computing. While various analysts recognize the company's considerable investments in hybrid cloud and AI, concerns about its valuation and past performance also emerge. Analysts generally agree that despite some execution slip-ups, IBM maintains strong software capabilities and a promising future, particularly with its $1.3 trillion addressable market in quantum computing by 2030. Overall, while some view IBM as a buying opportunity, others express worries about its competitive position and valuation metrics.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
MSFT
BUY ON WEAKNESS

It sank 6.6% right after earnings. The market got it wrong--this is a buy opportunity. After a lost decade, they returned to growth a few years ago. They spun off their legacy business and doubled-down on their Red Hat division, essential for AI. Rallied 34% last year, and held up even when AI corrected. YOY revenue was +2%, software +7%, consulting -2% and infrastructure -6%. Bountiful cash flow, though. Also, the reiterated full-year guidance. The quarter and business are good.

SELL

Between hardware and software, higher margins and greater growth still belong to the software side. He's looking more to consulting, with its higher margins.

BUY

Legacy tech giants like this have been some of the top names this year and are a good place to hide. They boast strong earnings, reasonable valuations and good growth in AI.

PAST TOP PICK
(A Top Pick Mar 13/24, Up 30%)

It wasn't seen as an AI play until their partnership with Microsoft. Shares then rallied. He sold around $235 after the PE jumped as its value dropped. 

HOLD

He added it last May, and up 51% since. Today's more fully valued at 23x. Remains a long-term hold, given their AI consulting.

premiumPremium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK

Can a stock that's rallied 36% in the past year be considered a dark horse? IBM can. It outpaced the higher-profile Apple, which climbed 25.5% in the last 12 months and Alphabet by 3%. What is IBM doing right? Software. It's shed its old identity as a stodgy hardware company and tilted hard into software. True, shares dipped last October when they missed their numbers in the consulting segment, but shares jumped this week from $228 to $258 after they reported.

PAST TOP PICK
(A Top Pick Mar 13/24, Up 33%)

Bought on promise of its AI partnerships. Moved up steadily, but he worried that legacy businesses were lagging. He sold when valuations got into low 20s. Have to know when to buy, and when to sell.

BUY

It just reported great numbers and shares jumped 13%. Redhat has made this an AI winner. It rallied 34% last year. They've had 6 straight quarters of positive sales growth, leading to an earnings beat and excellent free cash flow. Their full year forecast includes accelerating revenue growth and free cash flow. YOY growth: infrastructure -8%, consulting -2%, software 10% which is the largest segment, amounting to 43% of 2024 revenues. Software got stronger as 2024 wore on, and this segment could make up 50% of IBM's business. Specifically, Red Hat grew 16% YOY in Q4 and automation 15%. Watson X and Red Hat are key growers, enjoying the AI tailwind. Their GenAI business generates over $5 billion of business, growing by $2 billion, quarter-over-quarter. That said, shares went sideways last October given a miss in their consulting business, but the CEO feels AI will return this segment to growth in 2026. Tailwinds: a good backlog, record signing in Q4, and business in GenAI all support accelerating growth in low-single digits. Caveat: their PE is 24x PE and 22x in 2026, instead of around 10x, but their return to steady growth justifies the PE and software will generate more recurring revenue. An indirect AI play that won't be hurt by DeepSeek.

DON'T BUY

There are better tech stocks, like MSFT and Google. It's been restructuring for many, many years. They've acquired some prudent companies, but also carry many legacy assets that are obsolete in the current world.

WATCH

He owns MSFT, and it's also involved in quantum computing. Other names to think about are GOOG, AMZN, and Toshiba from Japan.

If you double your money, do the smart thing and sell half. These tech stocks are 3x riskier than the market if interest rates go up. It's about managing risk in your portfolio. 

BUY

It's still inexpensive, still has upside at 22x PE.

PARTIAL BUY

Lots of horses, but he hesitates because it's sitting around $230 with a price target of $257. Runway is a bit shorter. Add here and around $220, and certainly around $210.

WEAK BUY

Decent. She prefers names with better growth profiles. Spun off mainframe business, which improves growth profile. Now just consulting. Stock's done well, now getting into cybersecurity and AI.

BUY

They report next week. The CEO pulled it off through M&A and now we're seeing growth.

BUY

They report next week. A pleasant surprise, up 42% this year. They pulled it off with Red Hat and now with AI. 

Showing 31 to 45 of 447 entries